Business
Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants
Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warr...
About this update from Cosciens Biopharma Inc.
[{"type":"text","content":"\n\n\n\nAeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants\nCanada NewsWire\nQUEBEC CITY, Nov. 2, 2015\n\n\n\nAll references to dollars are to United States dollars\n\n\n\nQUEBEC CITY, Nov. 2, 2015 /CNW/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the \"Company\") announced today that the holders (the \"Participating Holders\") of substantially all of its remaining outstanding Series B Common Share Purchase Warrants (the \"Series B Warrants\") have agreed to exercise all of the approximately 4.1 million Series B Warrants held by them as promptly as practicable at a maximum exercise ratio of approximately 33.23 Common Shares per Series B Warrant in accordance with the alternate cashless exercise feature in such Series B Warrants.  Following the exercise of Series B Warrants by the Participating Holders in accordance with the terms of the agreement, approximately 0.8 million Series B Warrants, with an expiry date of September 12, 2016, will remain outstanding, representing approximately 2.7% of the originally issued number of Series B Warrants.\n\nDavid A. Dodd, Chairman, President and Chief Executive Officer of the Company remarked regarding this development, \"With the uncertainty about future additional dilution from the Series B Warrants now substantially resolved, it is time to focus on the fundamentals of this Company, which I believe are very strong.  I am excited about the opportunity to create shareholder value with our internally developed products and our growing externally sourced portfolio.  We are making significant progress on both fronts.  I am looking forward to providing updates regarding our progress during our quarterly conference call on Friday, November 6, 2015.\"\n\nIn order to accommodate some of the Participating Holders' internal policies, the Company has agreed that one or more of the Participating Holders will not be required to ex...